共 104 条
- [21] Keung YK(2020)Immunosuppression and growth factors for severe aplastic anemia: new data for old questions Haematologica 105 1170-79
- [22] Pettenati MJ(2017)Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia N Engl J Med 376 1540-207
- [23] Cruz JM(2018)Paediatric amendment to adult BSH Guidelines for aplastic anaemia Br J Haematol 180 201-46
- [24] Rauff B(2013)Standard treatment of acquired SAA in adult patients 18–40 years old with an HLA-identical sibling donor Bone Marrow Transpl 48 178-28
- [25] Idrees M(2016)British Society for Standards in Haematology. Guidelines for the diagnosis and management of adult aplastic anaemia Br J Haematol 172 187-9
- [26] Shah SA(2012)Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience Br J Haematol 157 339-38
- [27] Korgaonkar S(2018)Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment Blood Adv 2 2020-31
- [28] Ghosh K(2020)Blood and bone marrow transplantation in India: Past, present, and future Indian J Med Paediatr Oncol 41 308-e81
- [29] Jijina F(2013)The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia—a retrospective analysis from three Indian centers Clin Transplant 27 923-8
- [30] Vundinti BR(2014)Outcome of pediatric acquired aplastic anemia: a developing world experience Pediatr Hematol Oncol 31 29-9